CORNER GROWTH ACQUISITION CORP. 2

2024 Q2 Form 10-Q Financial Statement

#000141057824001464 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2

Balance Sheet

Concept 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.43K
YoY Change
Cash & Equivalents $18.43K
Short-Term Investments
Other Short-Term Assets $40.72K
YoY Change -86.43%
Inventory
Prepaid Expenses $40.72K
Receivables
Other Receivables
Total Short-Term Assets $59.16K
YoY Change -81.37%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.316M
YoY Change -73.81%
Other Assets
YoY Change
Total Long-Term Assets $5.316M
YoY Change -73.77%
TOTAL ASSETS
Total Short-Term Assets $59.16K
Total Long-Term Assets $5.316M
Total Assets $5.375M
YoY Change -73.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $450.00
YoY Change 0.0%
Accrued Expenses $3.019M
YoY Change -7.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.663M
YoY Change 18.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $6.808M
YoY Change -10.41%
Total Long-Term Liabilities $6.808M
YoY Change -10.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.663M
Total Long-Term Liabilities $6.808M
Total Liabilities $11.47M
YoY Change -0.88%
SHAREHOLDERS EQUITY
Retained Earnings -$11.41M
YoY Change 1.39%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$11.41M
YoY Change
Total Liabilities & Shareholders Equity $5.375M
YoY Change -73.89%

Cashflow Statement

Concept 2024 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#FairValueAdjustmentOfWarrants
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2024#FairValueAdjustmentOfWarrants
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001847513
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
tronu Threshold Business Days For Redemption Of Public Shares
ThresholdBusinessDaysForRedemptionOfPublicShares
P10D
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
CORNER GROWTH ACQUISITION CORP. 2
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity File Number
EntityFileNumber
001-40510
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1582723
dei Entity Address Address Line1
EntityAddressAddressLine1
251 Lytton Avenue, Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94301
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
543-8180
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 us-gaap Cash
Cash
18433
CY2023Q4 us-gaap Cash
Cash
18970
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
40724
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
22702
CY2024Q2 us-gaap Assets Current
AssetsCurrent
59157
CY2023Q4 us-gaap Assets Current
AssetsCurrent
41672
CY2024Q2 tronu Assets Held In Trust Account
AssetsHeldInTrustAccount
5316054
CY2023Q4 tronu Assets Held In Trust Account
AssetsHeldInTrustAccount
21200364
CY2024Q2 us-gaap Assets
Assets
5375211
CY2023Q4 us-gaap Assets
Assets
21242036
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
450
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
450
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1643708
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1065496
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3018959
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3005916
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4663117
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4071862
CY2024Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
333482
CY2023Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
333482
CY2024Q2 tronu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
6475000
CY2023Q4 tronu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
6475000
CY2024Q2 us-gaap Liabilities
Liabilities
11471599
CY2023Q4 us-gaap Liabilities
Liabilities
10880344
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11412905
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10839135
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-11412442
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-10838672
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5375211
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21242036
CY2024Q2 tronu Operating And Formation Costs
OperatingAndFormationCosts
154023
tronu Operating And Formation Costs
OperatingAndFormationCosts
573770
CY2023Q2 tronu Operating And Formation Costs
OperatingAndFormationCosts
730559
tronu Operating And Formation Costs
OperatingAndFormationCosts
1231028
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-154023
us-gaap Operating Income Loss
OperatingIncomeLoss
-573770
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-730559
us-gaap Operating Income Loss
OperatingIncomeLoss
-1231028
CY2024Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
56730
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
295468
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
256947
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
465901
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-166741
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
253151
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1000444
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
69448
us-gaap Net Income Loss
NetIncomeLoss
-278302
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-726763
us-gaap Net Income Loss
NetIncomeLoss
-1765571
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-10838672
CY2024Q1 tronu Initial Measurement Of Common Stock Subject To Redemption Against Additional Paid In Capital Value
InitialMeasurementOfCommonStockSubjectToRedemptionAgainstAdditionalPaidInCapitalValue
238738
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-347750
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-11425160
CY2024Q2 tronu Initial Measurement Of Common Stock Subject To Redemption Against Additional Paid In Capital Value
InitialMeasurementOfCommonStockSubjectToRedemptionAgainstAdditionalPaidInCapitalValue
56730
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
69448
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-11412442
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-9023990
CY2023Q1 tronu Initial Measurement Of Common Stock Subject To Redemption Against Additional Paid In Capital Value
InitialMeasurementOfCommonStockSubjectToRedemptionAgainstAdditionalPaidInCapitalValue
208954
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1038808
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-10271752
CY2023Q2 tronu Initial Measurement Of Common Stock Subject To Redemption Against Additional Paid In Capital Value
InitialMeasurementOfCommonStockSubjectToRedemptionAgainstAdditionalPaidInCapitalValue
256947
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-726763
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-11255462
us-gaap Profit Loss
ProfitLoss
-278302
us-gaap Profit Loss
ProfitLoss
-1765571
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
295468
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
465901
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1000444
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13043
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
749164
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
18022
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
37631
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
578212
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
430764
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-537
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-88731
tronu Payments For Investment Of Cash In Trust Account
PaymentsForInvestmentOfCashInTrustAccount
130000
tronu Payments For Investment Of Cash In Trust Account
PaymentsForInvestmentOfCashInTrustAccount
854799
tronu Proceeds Received From Trust Account
ProceedsReceivedFromTrustAccount
16309778
tronu Proceeds Received From Trust Account
ProceedsReceivedFromTrustAccount
57176699
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16179778
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
56321900
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
130000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
854799
tronu Payments For Redemption Of Common Stock
PaymentsForRedemptionOfCommonStock
16309778
tronu Payments For Redemption Of Common Stock
PaymentsForRedemptionOfCommonStock
57176699
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
7800
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16179778
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-56329700
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-537
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-96531
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18970
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117686
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18433
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21155
tronu Remeasurement Of Class Ordinary Shares Subject To Possible Redemption
RemeasurementOfClassOrdinarySharesSubjectToPossibleRedemption
295468
tronu Remeasurement Of Class Ordinary Shares Subject To Possible Redemption
RemeasurementOfClassOrdinarySharesSubjectToPossibleRedemption
465901
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
448
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-02-10
CY2024Q2 tronu Transaction Costs.
TransactionCosts.
10873351
CY2024Q2 tronu Sale Of Stock Underwriting Fees
SaleOfStockUnderwritingFees
3700000
CY2024Q2 tronu Deferred Underwriting Compensation Noncurrent
DeferredUnderwritingCompensationNoncurrent
6475000
CY2024Q2 tronu Sale Of Stock Other Offering Costs
SaleOfStockOtherOfferingCosts
698351
CY2024Q2 us-gaap Share Price
SharePrice
10.00
CY2024Q2 tronu Percentage Of Redeeming Shares Of Public Shares Without Company Prior Written Consent
PercentageOfRedeemingSharesOfPublicSharesWithoutCompanyPriorWrittenConsent
0.15
CY2024Q2 tronu Percentage Of Public Shares To Be Redeemed On Non Completion Of Business Combination
PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
1
CY2023Q1 us-gaap Share Price
SharePrice
0.04
CY2023Q1 tronu Trust Account Deposit
TrustAccountDeposit
65000.00
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.48
CY2024Q1 tronu Minimum Public Holders Requirement For Listing Stock Market
MinimumPublicHoldersRequirementForListingStockMarket
300
tronu Dissolution Expense
DissolutionExpense
100000
CY2024Q2 us-gaap Share Price
SharePrice
10.00
CY2024Q2 us-gaap Cash
Cash
18433
CY2024Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
5316054
CY2024Q2 tronu Working Capital Deficit
WorkingCapitalDeficit
4603960
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. As of June 30, 2024, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks.</p>
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q2 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
480000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2023 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
tronu Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2024Q2 tronu Deferred Underwriting Fee Per Unit
DeferredUnderwritingFeePerUnit
0.35
CY2024Q2 tronu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
6475000
tronu Warrant Expiration Term
WarrantExpirationTerm
P5Y
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001410578-24-001464-index-headers.html Edgar Link pending
0001410578-24-001464-index.html Edgar Link pending
0001410578-24-001464.txt Edgar Link pending
0001410578-24-001464-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tronu-20240630.xsd Edgar Link pending
tronu-20240630x10q.htm Edgar Link pending
tronu-20240630xex31d1.htm Edgar Link pending
tronu-20240630xex31d2.htm Edgar Link pending
tronu-20240630xex32d1.htm Edgar Link pending
tronu-20240630xex32d2.htm Edgar Link pending
tronu-20240630_cal.xml Edgar Link unprocessable
tronu-20240630_def.xml Edgar Link unprocessable
tronu-20240630_lab.xml Edgar Link unprocessable
tronu-20240630_pre.xml Edgar Link unprocessable
tronu-20240630x10q_htm.xml Edgar Link completed